ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Tilray Brands Inc

Tilray Brands Inc (2HQ)

1.2225
-0.0105
(-0.85%)
Closed December 04 4:00PM
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.2225
Bid
1.214
Ask
1.2305
Volume
158,809
1.2175 Day's Range 1.2515
0.00 52 Week Range 0.00
Market Cap
Previous Close
1.233
Open
1.2365
Last Trade
800
@
1.23
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
842,961,757
Dividend Yield
-
PE Ratio
-4.40
Earnings Per Share (EPS)
-0.29
Revenue
804.73M
Net Profit
-244.98M

About Tilray Brands Inc

Sector
Medicinal Chems,botanicl Pds
Industry
Medicinal Chems,botanicl Pds
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Tilray Brands Inc is listed in the Medicinal Chems,botanicl Pds sector of the Tradegate (DE) with ticker 2HQ. The last closing price for Tilray Brands was 1.23 €. Over the last year, Tilray Brands shares have traded in a share price range of 0.00 € to 0.00 €.

Tilray Brands currently has 842,961,757 shares outstanding. The market capitalization of Tilray Brands is 1.04 € billion. Tilray Brands has a price to earnings ratio (PE ratio) of -4.40.

2HQ Latest News

Tilray Medical bringt erste in Deutschland angebaute kommerzielle medizinische Cannabisprodukte unter neu erweiterter Anbaulizenz auf den Markt

Tilray Medical bringt erste in Deutschland angebaute kommerzielle medizinische Cannabisprodukte unter neu erweiterter Anbaulizenz auf den Markt NEUMÜNSTER, Deutschland, Nov. 14, 2024 (GLOBE...

Tilray Medical lance ses premiers produits commerciaux à base de cannabis thérapeutique « cultivés en Allemagne » dans le cadre de son autorisation de culture récemment étendue

Tilray Medical lance ses premiers produits commerciaux à base de cannabis thérapeutique « cultivés en Allemagne » dans le cadre de son autorisation de culture récemment étendue NEUMÜNSTER...

Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License

Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License NEUMÜNSTER, Germany, Nov. 14, 2024 (GLOBE NEWSWIRE...

Tilray Medical annonce les résultats positifs d’une étude sur l’extrait de cannabis oral dans le traitement des vomissements induits par la chimiothérapie

Tilray Medical annonce les résultats positifs d’une étude sur l’extrait de cannabis oral dans le traitement des vomissements induits par la chimiothérapie SYDNEY, Australie, 07 nov. 2024 (GLOBE...

Tilray Medical gibt positive Ergebnisse einer Studie zu oralem Cannabisextrakt bei durch Chemotherapie induziertem Erbrechen bekannt

Tilray Medical gibt positive Ergebnisse einer Studie zu oralem Cannabisextrakt bei durch Chemotherapie induziertem Erbrechen bekannt SYDNEY, Australien, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray...

Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis

Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis SYDNEY, Australia, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of...

Tilray Medical bringt die Cannabis-Marke Redecan in Australien auf den Markt

Tilray Medical bringt die Cannabis-Marke Redecan in Australien auf den Markt EU-GMP-zertifiziertes Redecan Cannabis jetzt in Australien auf ärztliche Verschreibung erhältlichNEW YORK, Sept. 18...

Tilray Medical lance la marque de cannabis Redecan en Australie

Tilray Medical lance la marque de cannabis Redecan en Australie Le cannabis Redecan, certifié BPF-UE, est désormais disponible sur prescription médicale en AustralieNEW YORK, 18 sept. 2024...

Tilray Medical Launches Redecan Cannabis Brand in Australia

Tilray Medical Launches Redecan Cannabis Brand in Australia EU-GMP Certified Redecan Cannabis Now Available in Australia with Medical PrescriptionNEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE...

Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms

Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms LISBON...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
P1MOrdinary Shares
0.771 €
(2,012.33%)
11.77k
BLEBluebird bio Inc
0.6568 €
(92.33%)
191.66k
PA8Paion AG
0.0184 €
(58.62%)
27.5k
9SCManganese X Energy Corp
0.0374 €
(50.81%)
54k
SQHSpearmint Resources Inc
0.017 €
(41.67%)
581.39k
4E2Relmada Therapeutics Inc
0.605 €
(-77.08%)
51.57k
L7C2Windfall Geotek Inc
0.0035 €
(-58.82%)
150.12k
R1EAEV Resources Ltd
0.0014 €
(-46.15%)
38k
BVU3St James Gold Corp
0.065 €
(-39.25%)
10k
UH7ATennant Minerals NL
0.007 €
(-39.13%)
20k
PF8European Lithium Limited
0.0318 €
(-21.67%)
24.15M
D7GNel ASA
0.2699 €
(8.92%)
7.96M
AXIAtos SE
0.3199 €
(-25.78%)
4.47M
BT81PowerHouse Energy Group Plc
0.0124 €
(0.00%)
1.85M
I5RImage Resources NL
0.059 €
(7.27%)
1.78M

Discussion

View Full Feed
leverage102 leverage102 27 seconds ago
Republican President-elect Donald Trump has said his election victory handed him an “unprecedented and powerful” mandate to govern.
He beat Democratic rival Kamala Harris in all seven closely watched swing states, giving him a decisive advantage overall.
Trump’s party has also won both
StockInfo11 StockInfo11 31 seconds ago
https://youtu.be/blV4IYK8-_4
West Red Lake Gold Mines (WRLG.v or WRLGF for US investors) is progressing toward restarting gold production at the Madsen mine in Ontario’s Red Lake district. CEO Shane Williams highlighted WRLG's 1.7M oz Au resource, 50,000m of drilling, infrastructure upgrades,
FFFacts FFFacts 41 seconds ago
They should appeal . I don't remember what the amount was set aside but it doesn't matter because that can also be changed. A court order will have no effect on the letter agreement.
FNMA
lighter than AIR lighter than AIR 46 seconds ago
Hopium…is more accurate.
BMXI
GREGG THE GREEK GREGG THE GREEK 1 minute ago
LOL I remember.
RDAR
Greky Greky 1 minute ago
Once again 52-weeks high
HOOD
arizona1 arizona1 1 minute ago
AOC may throw name in mix for top Dem spot on House Oversight Committee

Several aging Democratic committee members face challenges from younger colleagues
https://www.foxnews.com/politics/aoc-could-throw-name-mix-top-dem-spot-house-oversight-committee-report

The
EnchantedNomad841 EnchantedNomad841 2 minutes ago
Not sure why im in jail but meybe i can get a pardon from biden :))))))))&
GREGG THE GREEK GREGG THE GREEK 2 minutes ago
We go back many, many, years.

Met on a play and had some fun with it and a few others back in the day. Good dude.


RDAR
RDAR
Red_Right_Hand Red_Right_Hand 2 minutes ago
https://www.acaglobal.com/insights/new-sec-rule-short-selling-key-filing-requirements-and-deadlines-form-sho
https://www.sec.gov/files/rules/final/2023/34-98738.pdf
NWBO
xxxx xxxx 2 minutes ago
Your Eldorado is on the Horizon !
https://www.youtube.com/watch?v=MQr2WmsPrAo

:) :)
SHIBUSD
LowFloatLopes LowFloatLopes 3 minutes ago
We're pretty much based in the low .20s now ... Less than two weeks ago, we were back down to seven cents ...we're trekkin in the right direction folks!! 
AZRH
Tadaaa Tadaaa 3 minutes ago
Good data Sam, TY, charts needed a burp, good to go
HBARUSD
RichieBoy RichieBoy 3 minutes ago
Golf I hunch he's actually referring to any possibility of uplisting on a senior exchange. In which case we don't know the seniority or size of the acquisition yet. To determine how long it would take for AFFU to qualify with the SEC for the acquisition.... Whew! Might sound pretentious but we reall
AFFU
Gamco Gamco 3 minutes ago
Interesting post on LinkedIn:


IDCC
RIGATONI RIGATONI 3 minutes ago
$14.99 ~Rig
EquityMonster83 EquityMonster83 4 minutes ago
Have they stopped reporting earnings?
TANH
ORCA ORCA 4 minutes ago
I WAS AT .0084 THEN .0085 AND THEN .0086.I GOT NOTHING.THANKFULLY SOME IDIOT PUT A BLOCK AT .009 AND I TOOK IT WITH ONE HIT.KEEP THEM COMING.
12/04/2024 Buy
Trade Details
VDRM
VIADERMA INC
504,405
$0.009 $3.00 -$4,542.65
VDRM
jtomm jtomm 4 minutes ago
I'm curious as to which calls you like. Near term, long term, in the money, out of the money? I haven't bought any yet, but I'm kind of liking the deep in the money Jun '25 calls as a way to get a little leverage for not much cost, and then maybe a little at the money or out of the money for more sp
ARWR
sylvia07 sylvia07 5 minutes ago
Well said, Jimmie Joe, patience will pay off!
DBMM
doccjc doccjc 5 minutes ago
IDE application to be submitted and ultimately approved and the present share price, along with a certain poster will be in the rear view mirror.
Human trials in SE Asia just around the corner. We're about to find out how effective RadioGel is in humans.
Wonder where the share price w
RDGL
iamthe walrus iamthe walrus 5 minutes ago
Core Optics , Core SS llc both Virginia business got about 700 million shares in the share exchange with Coretecs. Those shares are being held at Core SS llc where Roberto Kim is the Director . He was our CFO after the deal closed Aug 22 2024 . He was also from xtomorrow and xtequity equity. After
CRTG
RIGATONI RIGATONI 5 minutes ago
$14.75 took more ~Rig
Halkid Halkid 5 minutes ago
That’s what I’m saying ,this company will do great!
SPZI
gitreal gitreal 5 minutes ago
This is the fourth or maybe fifth time you've posted the PR headlines, yet you won't address the ridiculous rhodium/PGM thing, and why the last company quarterly never mentioned them. Tough to explain that, eh?

And there's the mine and mill that MSHA say are abandoned, yet the comp
NBRI